New synthetic method for indole-2-carboxylate and its application to the total synthesis of duocarmycin SA

Organic Letters

Volumn 6, Issue 17, 2004, Pages 2953-2956

  Hiroya, Kou ^a   Matsumoto, Shigemitsu ^a   Sakamoto, Takao ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 INDOLECARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; DUOCARMYCIN SA; HALIDE; PALLADIUM;

ARTICLE; CATALYSIS; CHEMICAL REACTION; CYCLIZATION; DRUG SYNTHESIS; ELECTRON; HYDROGENATION; PROTON NUCLEAR MAGNETIC RESONANCE; TECHNIQUE;

CYCLIZATION; INDOLES; MOLECULAR STRUCTURE; PYRROLES;

EID: 4444243019     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0489548     Document Type: Article

References (26)

1. (a) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 1045.
2. (b) Sundberg, R. J. Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Ress, C. W., Scriven, E. F. V., Bird, C. W., Eds.; Pergamon Press: Oxford, 1996; Vol. 2, p 119.
3. (a) Hiroya, K.; Itoh, S.; Sakamoto, T. J. Org. Chem. 2004, 69, 1126.
4. (b) Hiroya, K.; Itoh, S.; Ozawa, M.; Sakamoto, T. Tetrahedron Lett. 2002, 43, 1277.
5. Anastasia, L.; Negishi, E. Org. Lett. 2001, 3, 3111.
6. (a) Tykwinski, R. R. Angew. Chem., Int. Ed. 2003, 42, 1566.
7. (b) Negishi, E.; Yves, D. In Handbook of Organopalladium Chemistry for Organic Synthesis; Negishi, E., Ed.; John Wiley & Sons: Hoboken, NJ, 2002; Vol. 1.
8. Yasuhara, A.; Sakamoto, T. Tetrahedron Lett. 1998, 39, 595.
9. The reason for the low conversion of the electron rich compounds is not totally clear, but one possibility may be the presence of an undesired deactivation cycle of the catalyst.
10. For examples, see: (a) Esseveldt, B, C, J.; Delft, F. L.; Gelder, R.; Rutjes, F. P. J. T. Org. Lett. 2003, 5, 1717. (b) Larock, R. C.; Yum, E. K.; Refvik, M. D. J. Org. Chem. 1998, 63, 7652. (c) Yu, M. S.; Leon, L. L.; McGguire, M. A.; Botha, G. Tetrahedron Lett. 1998, 39, 9347.
11. For examples, see: (a) Esseveldt, B, C, J.; Delft, F. L.; Gelder, R.; Rutjes, F. P. J. T. Org. Lett. 2003, 5, 1717. (b) Larock, R. C.; Yum, E. K.; Refvik, M. D. J. Org. Chem. 1998, 63, 7652. (c) Yu, M. S.; Leon, L. L.; McGguire, M. A.; Botha, G. Tetrahedron Lett. 1998, 39, 9347.
12. For examples, see: (a) Esseveldt, B, C, J.; Delft, F. L.; Gelder, R.; Rutjes, F. P. J. T. Org. Lett. 2003, 5, 1717. (b) Larock, R. C.; Yum, E. K.; Refvik, M. D. J. Org. Chem. 1998, 63, 7652. (c) Yu, M. S.; Leon, L. L.; McGguire, M. A.; Botha, G. Tetrahedron Lett. 1998, 39, 9347.
13. (a) Ichimura, M.; Ogawa, T.; Takahashi, K.; Kobayashi, E.; Kawamoto, I.; Yasuzawa, T.; Takahashi, I.; Nakano, H. J. Antibiot. 1990, 43, 1037.
14. (b) Yasuzawa, T.; Saitoh, Y.; Ichimura, M.; Takahashi, I.; Sano, H. J. Antibiot. 1991, 44, 445.
15. (c) For review, see: Boger, D. L.; Johnson, D. S. Angew. Chem., Int. Ed. Engl. 1996, 35, 1438.
16. Boger, D. L.; Machiya, K. J. Am. Chem. Soc. 1992, 114, 10056.
17. (a) Muratake, H.; Matsumura N. Natsume M. Chem. Pharm. Bull. 1995, 35, 1064.
18. (b) Muratake, H.; Abe, I.; Natsume, M. Chem. Pharm. Bull. 1996, 44, 67.
19. (c) Muratake, H.; Tonegawa, M.; Natsume, M. Chem. Pharm. Bull. 1998, 46, 400.
20. Fukuda, Y.; Terashima, S. Tetrahedron Lett. 1997, 38, 7207.
21. Yamada, K.; Kurokawa, T.; Tokuyama, H.; Fukuyama, T. J. Am Chem. Soc. 2003, 125, 6630.
22. For a review, see: Boger, D. L.; Boyce, C. W.; Garbaccio, R. M.; Goldberg, J. A. Chem. Rev. 1997, 97, 787.
23. Tietze, L. F.; Haunert, F.; Feuerstein, T.; Herzig, T. Eur. J. Org. Chem. 2003, 562 and references therein.
24. More than half of the epoxide 23 was decomposed during the isolation and the purification. Therefore, 23 could not be characterized.
25. (a) Boger, D. L.; Ishizaki, T.; Zarrinmayeh, H.; Munk, S. A., Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1990, 112, 8961.
26. (b) Fukuda, Y.; Itoh, Y.; Nakatani, K.; Terashima, S. Tetrahedron 1994, 50, 2793.